• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利福平经皮给药的实验溶解度、热力学/计算验证及基于 GastroPlus 的计算机预测。

Experimental Solubility, Thermodynamic/Computational Validations, and GastroPlus-Based In Silico Prediction for Subcutaneous Delivery of Rifampicin.

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.

Department of Medical Laboratory Technology, University Polytechnic, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, 835215, India.

出版信息

AAPS PharmSciTech. 2021 Mar 24;22(3):116. doi: 10.1208/s12249-021-01987-y.

DOI:10.1208/s12249-021-01987-y
PMID:33763801
Abstract

We focused to explore a suitable solvent for rifampicin (RIF) recommended for subcutaneous (sub-Q) delivery [ethylene glycol (EG), propylene glycol (PG), tween 20, polyethylene glycol-400 (PEG400), oleic acid (OA), N-methyl-2-pyrrolidone (NMP), cremophor-EL (CEL), ethyl oleate (EO), methanol, and glycerol] followed by computational validations and in-silico prediction using GastroPlus. The experimental solubility was conducted over temperature ranges T = 298.2-318.2 K) and fixed pressure (p = 0.1 MPa) followed by validation employing computational models (Apelblat, and van't Hoff). Moreover, the HSPiP solubility software provided the Hansen solubility parameters. At T = 318.2K, the estimated maximum solubility (in term of mole fraction) values of the drug were in order of NMP (11.9 × 10) ˃ methanol (6.8 × 10) ˃ PEG400 (4.8 × 10) ˃ tween 20 (3.4 × 10). The drug dissolution was endothermic process and entropy driven as evident from "apparent thermodynamic analysis". The activity coefficients confirmed facilitated RIF-NMP interactions for increased solubility among them. Eventually, GastroPlus predicted the impact of critical input parameters on major pharmacokinetics responses after sub-Q delivery as compared to oral delivery. Thus, NMP may be the best solvent for sub-Q delivery of RIF to treat skin tuberculosis (local and systemic) and cutaneous related disease at explored concentration.

摘要

我们专注于探索一种适合皮下(sub-Q)给药的利福平(RIF)推荐溶剂[乙二醇(EG)、丙二醇(PG)、吐温 20、聚乙二醇-400(PEG400)、油酸(OA)、N-甲基-2-吡咯烷酮(NMP)、吐温-EL(CEL)、油酸乙酯(EO)、甲醇和甘油],随后通过 GastroPlus 进行计算验证和计算机预测。实验溶解度在温度范围 T = 298.2-318.2 K 和固定压力(p = 0.1 MPa)下进行,然后使用计算模型(Apelblat 和 van't Hoff)进行验证。此外,HSPiP 溶解度软件提供了 Hansen 溶解度参数。在 T = 318.2 K 时,药物的估计最大溶解度(以摩尔分数表示)值的顺序为 NMP(11.9 × 10)>甲醇(6.8 × 10)>PEG400(4.8 × 10)>吐温 20(3.4 × 10)。药物溶解是吸热过程,从“明显的热力学分析”可以看出,熵驱动。活度系数证实了 RIF-NMP 相互作用有利于增加溶解度。最终,GastroPlus 预测了皮下给药相对于口服给药后关键输入参数对主要药代动力学反应的影响。因此,NMP 可能是 RIF 皮下给药治疗皮肤结核(局部和全身)和皮肤相关疾病的最佳溶剂,在探索的浓度下。

相似文献

1
Experimental Solubility, Thermodynamic/Computational Validations, and GastroPlus-Based In Silico Prediction for Subcutaneous Delivery of Rifampicin.利福平经皮给药的实验溶解度、热力学/计算验证及基于 GastroPlus 的计算机预测。
AAPS PharmSciTech. 2021 Mar 24;22(3):116. doi: 10.1208/s12249-021-01987-y.
2
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus-Based In Vivo Prediction in Humans: Part I.基于 HSPiP、计算和热力学模型优化的酒石酸托特罗定皮下给药溶剂及基于 GastroPlus 的人体体内预测:第一部分
AAPS PharmSciTech. 2024 May 1;25(5):93. doi: 10.1208/s12249-024-02800-2.
3
Thermodynamic, Computational Solubility Parameters in Organic Solvents and GastroPlus Based Prediction of Ketoconazole.酮康唑在有机溶剂中的热力学、计算溶解度参数及基于GastroPlus的预测
ACS Omega. 2021 Feb 11;6(7):5033-5045. doi: 10.1021/acsomega.0c06234. eCollection 2021 Feb 23.
4
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus‑Based In Vivo Prediction in Humans: Part II.基于 HSPiP、计算和热力学模型优化的酒石酸托特罗定皮下给药溶剂:第二部分。基于 GastroPlus 的体内预测在人类中的应用。
AAPS PharmSciTech. 2024 Jul 12;25(6):160. doi: 10.1208/s12249-024-02880-0.
5
Solubility measurement, Hansen solubility parameters and solution thermodynamics of gemfibrozil in different pharmaceutically used solvents.吉非贝齐在不同药用溶剂中的溶解度测定、Hansen 溶解度参数和溶液热力学。
Drug Dev Ind Pharm. 2019 Aug;45(8):1258-1264. doi: 10.1080/03639045.2019.1594884. Epub 2019 May 14.
6
Experimental Solubility of Ketoconazole, Validation Models, and In vivo Prediction in Human Based on GastroPlus.酮康唑的实验溶解度、验证模型及基于 GastroPlus 的人体体内预测。
AAPS PharmSciTech. 2021 Jun 28;22(5):194. doi: 10.1208/s12249-021-02075-x.
7
Solubility Data, Solubility Parameters and Thermodynamic Behavior of an Antiviral Drug Emtricitabine in Different Pure Solvents: Molecular Understanding of Solubility and Dissolution.溶解度数据、抗艾滋病药物恩曲他滨在不同纯溶剂中的溶解度参数和热力学行为:对溶解度和溶解的分子理解。
Molecules. 2021 Jan 31;26(3):746. doi: 10.3390/molecules26030746.
8
Solubility, Hansen Solubility Parameters and Thermodynamic Behavior of Emtricitabine in Various (Polyethylene Glycol-400 + Water) Mixtures: Computational Modeling and Thermodynamics.恩曲他滨在不同(聚乙二醇 400+水)混合物中的溶解度、Hansen 溶解度参数和热力学行为:计算建模和热力学。
Molecules. 2020 Mar 28;25(7):1559. doi: 10.3390/molecules25071559.
9
Solidified SNEDDS for the oral delivery of rifampicin: Evaluation, proof of concept, in vivo kinetics, and in silico GastroPlus simulation.固体自乳化给药系统(SNEDDS)用于口服利福平:评价、概念验证、体内动力学和 in silico GastroPlus 模拟。
Int J Pharm. 2019 Jul 20;566:203-217. doi: 10.1016/j.ijpharm.2019.05.061. Epub 2019 May 24.
10
Solubility determination of raloxifene hydrochloride in ten pure solvents at various temperatures: Thermodynamics-based analysis and solute-solvent interactions.盐酸雷洛昔芬在十种纯溶剂中不同温度下的溶解度测定:基于热力学的分析和溶质-溶剂相互作用。
Int J Pharm. 2018 Jun 10;544(1):165-171. doi: 10.1016/j.ijpharm.2018.04.024. Epub 2018 Apr 18.

引用本文的文献

1
Hansen Solubility Parameters, Computational, and Thermodynamic Models for Tofacitinib Citrate Solubility in Neat Mono Solvents, and GastroPlus Based Predicted In Vivo Performance of Subcutaneous Solution in Humans.用于预测枸橼酸托法替布在纯单一溶剂中溶解度的 Hansen 溶解度参数、计算模型和热力学模型,以及基于 GastroPlus 的皮下溶液在人体中的体内性能预测。
AAPS PharmSciTech. 2025 Feb 18;26(3):64. doi: 10.1208/s12249-025-03048-0.
2
The Application of a Physiologically Based Toxicokinetic Model in Health Risk Assessment.基于生理学的毒代动力学模型在健康风险评估中的应用。
Toxics. 2023 Oct 21;11(10):874. doi: 10.3390/toxics11100874.
3

本文引用的文献

1
Potential of nanoemulsions for intravenous delivery of rifampicin.纳米乳剂用于利福平静脉给药的潜力。
Pharmazie. 2008 Nov;63(11):806-11.
Preferential Solvation Study of Rosuvastatin in the {PEG400 (1) + Water (2)} Cosolvent Mixture and GastroPlus Software-Based In Vivo Predictions.
瑞舒伐他汀在{聚乙二醇400(1)+水(2)}混合助溶剂中的优先溶剂化研究及基于GastroPlus软件的体内预测
ACS Omega. 2023 Mar 28;8(14):12761-12772. doi: 10.1021/acsomega.2c07968. eCollection 2023 Apr 11.
4
Preferential Solvation Study of the Synthesized Aldose Reductase Inhibitor (SE415) in the {PEG 400 (1) + Water (2)} Cosolvent Mixture and GastroPlus-Based Prediction.合成醛糖还原酶抑制剂(SE415)在{聚乙二醇400(1)+水(2)}混合助溶剂中的优先溶剂化研究及基于GastroPlus的预测。
ACS Omega. 2022 Jan 2;7(1):1197-1210. doi: 10.1021/acsomega.1c05788. eCollection 2022 Jan 11.